Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic since the 1918 flu. The main challenges in mitigating COVID-19 are effective vaccination, treatment, and agile containm...
Main Authors: | Gunjan Arora, Jayadev Joshi, Rahul Shubhra Mandal, Nitisha Shrivastava, Richa Virmani, Tavpritesh Sethi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/8/1048 |
Similar Items
-
Vaccines: between benefits and concerns
by: Camelia C. DIACONU
Published: (2020-12-01) -
Viral pandemic preparedness: A pluripotent stem cell‐based machine‐learning platform for simulating SARS‐CoV‐2 infection to enable drug discovery and repurposing
by: Sally Esmail, et al.
Published: (2021-02-01) -
The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01) -
Human coronaviruses and therapeutic drug discovery
by: Lan-Gui Song, et al.
Published: (2021-03-01) -
Vaccines against Coronaviruses: The State of the Art
by: Cristiano Conte, et al.
Published: (2020-06-01)